Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,079,994
-
Share change
-
+1,331,864
-
Total reported value
-
$313,536,434
-
Put/Call ratio
-
0%
-
Price per share
-
$9.20
-
Number of holders
-
80
-
Value change
-
+$13,703,166
-
Number of buys
-
40
-
Number of sells
-
27
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2017
As of 31 Dec 2017 CYMABAY THERAPEUTICS INC - COM (CBAY) had 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 34,079,994 shares of stock of the company.
Largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, FMR LLC, Foresite Capital Management IV, LLC, Redmile Group, LLC, Vanguard Group Inc, FRANKLIN RESOURCES INC, Abingworth LLP, and FARALLON CAPITAL MANAGEMENT LLC.
This table shows 80 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.